SCHEMBL533156

SCHEMBL533156

Cc1cc(C)c(NS(=O)(=O)c2cc(Cl)cc(Cl)c2O)c(C)c1N

nearest known ligand 0.56

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ACLY P53396 17/20 0.56
F2 P00734 1/20 0.49
PRSS1 P07477 1/20 0.49
PRSS2 P07478 1/20 0.49
PRSS3 P35030 1/20 0.49
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
WDR5 P61964 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533141 0.82 ACLY (0.63) ACLYF2PRSS1PRSS2PRSS3
SCHEMBL532942 0.80 ACLY (0.51) ACLYF2PRSS1PRSS2PRSS3
SCHEMBL532815 0.78 ACLY (0.53) ACLY
SCHEMBL533015 0.77 ACLY (0.54) ACLY
SCHEMBL8321880 0.77 ACLY (0.47) ACLY
SCHEMBL534027 0.77 ACLY (0.55) ACLY
SCHEMBL532952 0.76 ACLY (0.51) ACLY
SCHEMBL533495 0.76 ACLY (0.57) ACLY
SCHEMBL533074 0.75 ACLY (0.49) ACLY
SCHEMBL14288686 0.75 ACLY (0.51) ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed